I recently attended a Digital Therapeutics (DTx) workflow workshop sponsored by the Digital Therapeutics Alliance and the National Council for Prescription Drug Programs (NCPDP)....
Recent Posts
Palm Trees, Ocean Breezes, & Interoperability: Reflections on ViVE2022
The inaugural ViVE conference kicked off March 6 in Miami Beach, boasting an impressive lineup of educational, exhibit hall, and networking opportunities that enabled attendees to...
7 Ways the Industry is Striving to Meet Consumers Where They Are
Healthcare delivery has been shifting over the past few years away from traditional sites of care, such as hospitals and clinics, to alternative sites of care, such as urgent care...
Key 2022 Health Care Regulatory and Policy Priorities to Navigate
Through its policy and regulatory mechanisms, the federal government is in the driver’s seat to drive and effect changes in health care and health information technology. The most...
Feds Officially Acknowledge Two NCPDP Standards. Part 2. What’s Next
By Pooja Babbrah, Practice Lead, PBM Services and Jocelyn Keegan, Payer/Practice Lead
Feds Officially Acknowledge Two NCPDP Standards. Part 1. Why This is a Big Deal
By Pooja Babbrah, Practice Lead, PBM Services and Jocelyn Keegan, Payer/Practice Lead
Emerging NCPDP Standard Enhancements to Improve Speed to Therapy for Specialty Medications
By Pooja Babbrah, Practice Lead, PBM Services
CARIN Alliance Workgroup to Help Advance Real-Time Pharmacy Benefit Check for Patients
By Pooja Babbrah, Practice Lead, PBM Services
Urgent Need for Real-Time Pharmacy Benefit Check Confirmed in Senate Committee Hearings
By Pooja Babbrah, PBM Services Practice Lead
The Time is Right for Canada to Incorporate a Naming Convention for Biologics and Biosimilars into its Emerging ePrescribing Infrastructure
By Pooja Babbrah, Senior Consultant
- 1
- 2
